AngioDynamics, Inc. (ANGO)
11.73
-0.08
(-0.68%)
USD |
NASDAQ |
Nov 06, 16:00
11.72
0.00 (0.00%)
After-Hours: 20:00
AngioDynamics Research and Development Expense (Annual) : 29.45M for May 31, 2026
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| May 31, 2026 | 29.45M |
| May 31, 2025 | 26.22M |
| May 31, 2024 | 31.51M |
| May 31, 2023 | 29.88M |
| May 31, 2022 | 30.74M |
| May 31, 2021 | 36.39M |
| May 31, 2020 | 29.68M |
| May 31, 2019 | 28.26M |
| May 31, 2018 | 24.34M |
| May 31, 2017 | 25.27M |
| May 31, 2016 | 25.05M |
| May 31, 2015 | 26.93M |
| May 31, 2014 | 27.49M |
| May 31, 2013 | 26.32M |
| Date | Value |
|---|---|
| May 31, 2012 | 20.51M |
| May 31, 2011 | 21.37M |
| May 31, 2010 | 19.28M |
| May 31, 2009 | 17.91M |
| May 31, 2008 | 14.42M |
| May 31, 2007 | 8.455M |
| May 31, 2006 | 5.869M |
| May 31, 2005 | 4.57M |
| May 31, 2004 | 3.551M |
| May 31, 2003 | 2.509M |
| May 31, 2002 | 1.951M |
| May 31, 2001 | 1.426M |
| May 31, 2000 | 1.642M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Globus Medical, Inc. | 146.94M |
| Abbott Laboratories | 2.889B |
| Alphatec Holdings, Inc. | 76.27M |
| AtriCure, Inc. | 90.17M |
| Baxter International, Inc. | 503.00M |